Carolyn Bonner is recorded as Board Member at Medicus Pharma Ltd. (MDCX) since September 2, 2025 and CFO at Medicus Pharma Ltd. (MDCX). The newest filing on record that lists Carolyn Bonner as CFO at Medicus Pharma Ltd. (MDCX) is dated May 4, 2026. Medicus Pharma Ltd. reported in an 8-K filed December 1, 2025 that Carolyn Bonner was appointed Chief Financial Officer, effective December 1, 2025. Medicus Pharma Ltd. reported in an 8-K filed September 12, 2025 that Carolyn Bonner was appointed acting Chief Financial Officer, effective September 12, 2025. Medicus Pharma Ltd. reported in an 8-K filed September 2, 2025 that Carolyn Bonner was appointed Member of Antev's Board of Directors. Carolyn Bonner has spoken on 1 investor event across 1 company, most recently for Medicus Pharma Ltd. on March 26, 2026. Medicus Pharma Ltd. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Medicus Pharma Ltd. includes Dr. Raza Bokhari (CEO), Faisal Mehmud (Chairman), Paul Marchetto (Chairman) and 5 others.
“Effective on December 1, 2025, Carolyn Bonner, President of the Company as well as Acting Chief Financial Officer of the Company since September 12, 2025 in Mr. Quinlan's absence, was appointed as Chief Financial Officer of the Company.”
Medicus Pharma Ltd. Form 8-K, filed December 1, 2025
· Read the filing
“In connection with Mr. Quinlan's medical leave of absence, Carolyn Bonner was appointed as acting Chief Financial Officer ("Acting CFO") of the Company.”
Medicus Pharma Ltd. Form 8-K, filed September 12, 2025
· Read the filing
Carolyn Bonner on recent calls
“Let me touch on a few of the financial highlights of our financial position, which you can find in greater detail in the annual report on Form 10-K we filed yesterday after market close.”
